|
"huang yf"的相关文件
显示项目 41-50 / 75 (共8页)
<< < 1 2 3 4 5 6 7 8 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2011-06-10 |
Association of CYP2E1, GST and mEH genetic polymorphisms with urinary acrylamide metabolites in workers exposed to acrylamide
|
Huang, YF;Chen, ML;Liou, SH;Chen, MF;Uang, SN;Wu, KY |
| 國家衛生研究院 |
2011-03 |
Biological monitoring for occupational acrylamide exposure from acrylamide production workers
|
Huang, YF;Wu, KY;Liou, SH;Uang, SN;Chen, CC;Shih, WC;Lee, SC;Huang, CCJ;Chen, ML |
| 中山醫學大學 |
2011 |
Treatment of persistent idiopathic facial pain (PIFP) with a low-level energy diode laser.
|
Yang, HW; Huang, YF |
| 中山醫學大學 |
2011 |
Treatment of burning mouth syndrome with a low-level energy diode laser.
|
Yang, HW; Huang, YF |
| 國家衛生研究院 |
2010-07 |
Exposure assessment of airborne acrylamide for occupationally exposed workers by using an isotope-dilution gas Chromatography Coupled with Mass Spectrometry
|
Wu, KY;Huang, YF;Chen, MF;Shih, TS;Uang, SN;Mao, IF;Chen, ML |
| 中山醫學大學 |
2010 |
Becton Dickinson Biosciences CAM5.2 does not stand for true CK8/18. Comment on "Peripheral ameloblastoma in-situ: an evidential fact of surface epithelium origin", Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:763-7.
|
Wu, YL; Huang, YF; Hsu, JD; Han, CP |
| 國家衛生研究院 |
2009-10-01 |
Thapsigargin and flavin adenine dinucleotide ex vivo treatment rescues trafficking-defective gp91phox in chronic granulomatous disease leukocytes
|
Huang, YF;Liu, SY;Yen, CL;Yang, PW;Shieh, CC |
| 國家衛生研究院 |
2009-06 |
Investigations of clinical isolations of oral poliovirus vaccine strains between 2000 and 2005 in southern Taiwan
|
Chi, CY;Tseng, FC;Liu, DP;Chang, YW;Wu, HC;Huang, YF;Hwang, KP;Hsu, YW;Wang, SM;Liu, CC;Wu, HS;Yang, JY;Yang, CF;Wang, JR;Su, IJ |
| 國立臺灣大學 |
2009-04 |
Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes
|
Chou, WJ; Chou, MC; Tzang, RF; Hsu, YC; Gau, SS; Chen, SJ; Wu, YY; Huang, YF; Liang, HY; Cheng, H |
| 國立臺灣大學 |
2009-03 |
The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma.
|
Lin, ZZ; Hsu, HC; Hsu, CH; Yeh, PY; Huang, CY; Huang, YF; Chen, TJ; Kuo, SH; Hsu, C; Hu, FC; Jeng, YM; Chung, Y; Cheng, AL. |
显示项目 41-50 / 75 (共8页)
<< < 1 2 3 4 5 6 7 8 > >>
每页显示[10|25|50]项目
|
